Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Status:
Terminated
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of lithium combined with riluzole
to riluzole combined with placebo in people with amyotrophic lateral sclerosis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
ALS Association ALS Society of Canada Columbia University National Institute of Neurological Disorders and Stroke (NINDS) State University of New York - Upstate Medical University University of Kentucky University of Toronto